rs890129325
Variant summary
Our verdict is Likely benign. The variant received -1 ACMG points: 0P and 1B. BP4
The NM_213607.3(DNAAF19):c.5A>G(p.Glu2Gly) variant causes a missense change. The variant allele was found at a frequency of 0.00000999 in 1,602,250 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_213607.3 missense
Scores
Clinical Significance
Conservation
Publications
- primary ciliary dyskinesia 17Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae), PanelApp Australia, G2P
- primary ciliary dyskinesiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -1 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  0.0000131  AC: 2AN: 152240Hom.:  0  Cov.: 33 show subpopulations 
GnomAD2 exomes  AF:  0.00000417  AC: 1AN: 239558 AF XY:  0.00   show subpopulations 
GnomAD4 exome  AF:  0.00000966  AC: 14AN: 1450010Hom.:  0  Cov.: 31 AF XY:  0.00000693  AC XY: 5AN XY: 721566 show subpopulations 
Age Distribution
GnomAD4 genome  0.0000131  AC: 2AN: 152240Hom.:  0  Cov.: 33 AF XY:  0.0000269  AC XY: 2AN XY: 74378 show subpopulations 
Age Distribution
ClinVar
Submissions by phenotype
Primary ciliary dyskinesia    Uncertain:1 
This sequence change replaces glutamic acid with glycine at codon 2 of the CCDC103 protein (p.Glu2Gly). The glutamic acid residue is highly conserved and there is a moderate physicochemical difference between glutamic acid and glycine. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals affected with CCDC103-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C15"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at